KRRO — Korro Bio Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for Korro Bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—
Source:	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG
Status:	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	119	55.2	166	126
Net Total Accounts Receivable
Net Total Receivables	—	—	—	1.7
Prepaid Expenses
Total Other Current Assets
Total Current Assets	120	57.1	173	132
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	6.45	11.9	42.8	51.5
Long Term Investments
Other Long Term Assets
Total Assets	128	73.7	222	226
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	4.95	8.7	19.5	15
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	5.92	8.91	51.8	65.8
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	122	64.8	170	160
Total Liabilities & Shareholders' Equity	128	73.7	222	226
Total Common Shares Outstanding